跳至主要内容
临床试验/JPRN-jRCT1031220661
JPRN-jRCT1031220661招募中2 期

Exploratory study on the safety of oral administration of dapagliflozin for renal dysfunction in patients with unilateral nephrectomy - SADUN study

Yamada Daisuke0 个研究点目标入组 10 人开始时间: 2023年2月27日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 < 85age old(—)
性别
All

入选标准

  • 1. Patients with unilateral nephrectomy (regardless of time since nephrectomy)
  • 2. Patients with an eGFR of 25-59mL/min/1.73m2 for more than 3 months
  • 3. Age: Those who are between 18 and 85 years of age at the time of obtaining consent
  • 4. Male or female
  • 5. Those who have received a full explanation of the study and have given written consent of their own free will based on a full understanding of the study
  • 6. Those who can make outpatient visits in accordance with the research implementation schedule

排除标准

  • 1. Patients who need treatment such as anticancer drugs
  • 2. Patients with active renal or systemic inflammation
  • 3. Those who are allergic to dapagliflozin
  • 4. Those who are pregnant or may become pregnant
  • 5. Those who are breastfeeding
  • 6. Those who are judged inappropriate for participation in this study by the principal investigator or co-investigator

研究者

发起方
Yamada Daisuke

相似试验